...
首页> 外文期刊>Agricultural Sciences >Study on Parameters of Consumer Preferences for Alternative Wheat Products (Gluten-Free Foods) in USA and India
【24h】

Study on Parameters of Consumer Preferences for Alternative Wheat Products (Gluten-Free Foods) in USA and India

机译:美国和印度的替代小麦产品(不含麸质食品)的消费者偏好参数研究

获取原文
           

摘要

Celiac Disease (CD) is an inherited, autoimmune disorder in which proteins from the grains wheat, rye and barley (collectively called gluten) damage the small intestine. The only treatment for CD is a strict, lifelong gluten-free diet. With a prevalence rate of about one in 100-133 people worldwide. Celiac disease is wide-spread across the globe. Unlike traditional allergies, which cause immediate reactions, gluten sensitivity is harder to pin down since it manifests gradually and in various forms like headaches, stomach cramps, bloating, anxiety, and depression. Due to complicated diagnosis procedure and lack of awareness, many cases are either misdiagnosed or not at all diagnosed in India and USA. In spite of high growth, gluten-free foods are facing problems to grain ground in Asian market, due to high price, lack of awareness about the products, large number of un-diagnosed cases and inefficient value chain for gluten-free products. One of the major issues in India and USA is very high prices of gluten-free foods as compared to regular food products. Globally, the market potential of gluten free products is estimated to be USD 4639.13 Million and USD 7594.43 Million in 2015 and 2020 respectively. The global gluten free food market is projected to grow with a CAGR between 9 percent and 10.2 percent during 2016-2022. The study on consumer preference of gluten-free foods would enable manufacturers of gluten-free foods to understand the current and evolving expectations of consumers and to design the products according. Study of two countries i.e.>>, India and USA would enable manufacturers to understand the difference in choices and preferences related to gluten-free foods for both the nations. This study would help manufacturers of alternative wheat product to form the concrete marketing and product development strategy based on recent consumer behavior trends.
机译:腹腔疾病(CD)是一种遗传性自身免疫性疾病,其中小麦,黑麦和大麦谷粒中的蛋白质(统称为面筋)会破坏小肠。 CD的唯一治疗方法是严格的终生无麸质饮食。全世界的患病率约为100-133。腹腔疾病在全球范围内广泛传播。与引起立即反应的传统过敏症不同,面筋敏感性更难确定,因为它会以头痛,胃痉挛,腹胀,焦虑和抑郁等各种形式逐渐显现。由于诊断程序复杂且缺乏了解,在印度和美国,很多病例被误诊或根本没有被诊断。尽管增长迅速,但由于价格高,对产品的了解不足,大量未经诊断的病例以及无麸质产品的价值链效率低下,无麸质食品在亚洲市场面临着谷物问题。印度和美国的主要问题之一是与常规食品相比,无麸质食品的价格很高。在全球范围内,无麸质产品的市场潜力在2015年和2020年分别估计为4639.13百万美元和75.943亿美元。 2016-2022年,全球无麸质食品市场预计将以9%至10.2%的复合年增长率增长。对无麸质食品的消费者偏爱的研究将使无麸质食品的制造商能够了解消费者当前和不断发展的期望,并据此设计产品。对两个国家(em> ie > > ,印度和美国进行的研究将使制造商能够了解与无麸质食品有关的两种选择和偏好的差​​异。国家。这项研究将帮助替代小麦产品的制造商根据最近的消费者行为趋势形成具体的营销和产品开发策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号